A therapeutic and prophylactic method against a tumor treatable by endocrinine therapy, employing the combined use of a fibroblast growth factor receptor inhibitor and endocrinine therapy.
MA54311AUndetermined Publication Date: 2022-03-02TAIHO PHARMA CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA54311
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2018-11-26
- Filing Date
- 2019-11-25
- Publication Date
- 2022-03-02
Need to check novelty before this filing date? Find Prior Art
No text content released.